(Q39347246)

11 September 2017

title

Letter: Is diabetes mellitus a disorder of the glucoreceptor? (English)

1 reference

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A52024

8 April 2022

author name string

H Niki

series ordinal

2

1 reference

11 September 2017

A. Niki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A52024

8 April 2022

H. Niki

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A52024

8 April 2022

language of work or name

English

0 references

publication date

1 October 1975

1 reference

11 September 2017

4 October 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=52024

full work available at URL

8 April 2022

https://api.elsevier.com/content/article/PII:S0140673675901373?httpAccept=text/xml

1 reference

10.1016/S0140-6736(75)90137-3

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)90137-3

https://api.elsevier.com/content/article/PII:S0140673675901373?httpAccept=text/plain

8 April 2022

1 reference

10.1016/S0140-6736(75)90137-3

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)90137-3

8 April 2022

1 reference

11 September 2017

volume

2

1 reference

11 September 2017

issue

7936

1 reference

11 September 2017

page(s)

658

1 reference

Early Phase of Insulin Release

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Early insulin responses to glucose and to tolbutamide in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Decreased Sensitivity of the Pancreatic Beta Cells to Glucose in Prediabetic and Diabetic Subjects: A Glucose Dose-Response Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Acute and steady-state insulin responses to glucose in nonobese diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Studies of pancreatic alpha cell function in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Determination of pancreatic and gut Glucagon-Like Immunoreactivity (GLI) in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Abnormalities of glucagon metabolism in untreated diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Abnormal alpha cell function in diabetics response to insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Insulin Secretion by Anomers of D-Glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Anomeric Specificity of Glucose-Stimulated Insulin Release: Evidence for a Glucoreceptor?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Metabolic and insulin-releasing activities of D-glucose anomers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

The effect of glucose anomers upon insulin and glucagon secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Diazoxide and the treatment of hypoglycemia: an historical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Hyperosmolar nonketotic coma associated with diazoxide therapy for hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Phenothiazines and Diabetes in Hospitalized Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Glycemic effects of chlorpromazine in the mouse, hamster and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

Chlorpromazine-Induced Glucose Intolerance in the Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990137-3

7 January 2021

10.1016/S0140-6736(75)90137-3

Identifiers

DOI

1 reference

11 September 2017

1 reference